ENZEEVU Trademark

Trademark Overview


On Thursday, July 13, 2023, a trademark application was filed for ENZEEVU with the United States Patent and Trademark Office. The USPTO has given the ENZEEVU trademark a serial number of 98083674. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, July 9, 2024. This trademark is owned by Amgen Inc.. The ENZEEVU trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations and substances for use in the treatment of hematological, immune, autoimmune, inflammatory and respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances for the treatment of inflammatory disorders of the central nervous system; pharmaceutical preparations and substances used for the treatment of hemolytic anemia, thrombocytopenia and kidney failure
enzeevu

General Information


Serial Number98083674
Word MarkENZEEVU
Filing DateThursday, July 13, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, July 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 14, 2024

Trademark Statements


Goods and Servicespharmaceutical preparations and substances for use in the treatment of hematological, immune, autoimmune, inflammatory and respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances for the treatment of inflammatory disorders of the central nervous system; pharmaceutical preparations and substances used for the treatment of hemolytic anemia, thrombocytopenia and kidney failure

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, August 13, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSANDOZ AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBASEL 4051
CH

Party NameSANDOZ AG
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressBASEL 4051
CH

Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799

Trademark Events


Event DateEvent Description
Monday, July 17, 2023NEW APPLICATION ENTERED
Thursday, March 21, 2024ASSIGNED TO EXAMINER
Friday, March 22, 2024NON-FINAL ACTION WRITTEN
Friday, March 22, 2024NON-FINAL ACTION E-MAILED
Friday, March 22, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 5, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, April 5, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 5, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 5, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, April 5, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Friday, April 5, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, April 8, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 8, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 9, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 24, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 14, 2024PUBLISHED FOR OPPOSITION
Sunday, August 13, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 3, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, April 5, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 8, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 14, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 9, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT